FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2124673635> ?p ?o ?g. }

• W2124673635 endingPage "28" @default.
• W2124673635 startingPage "19" @default.
• W2124673635 abstract "The most successful clinical studies of immunotherapy in patients with non-Hodgkin's lymphoma (NHL) use the antibody rituximab (RTX) targeting CD20(+) B-cell tumors. Rituximab radiolabeled with β(-) emitters could potentiate the therapeutic efficacy of the antibody by virtue of the particle radiation. Here, we report on a direct radiolabeling approach of rituximab with the (99m)Tc- and (188)Re-tricarbonyl core (IsoLink technology).The native format of the antibody (RTX(wt)) as well as a reduced form (RTX(red)) was labeled with (99m)Tc/(188)Re(CO)(3). The partial reduction of the disulfide bonds to produce free sulfhydryl groups (-SH) was achieved with 2-mercaptoethanol. Radiolabeling efficiency, in vitro human plasma stability as well as transchelation toward cysteine and histidine was investigated. The immunoreactivity and binding affinity were determined on Ramos and/or Raji cells expressing CD20. Biodistribution was performed in mice bearing subcutaneous Ramos lymphoma xenografts.The radiolabeling efficiency and kinetics of RTX(red) were superior to that of RTX(wt) ((99m)Tc: 98% after 3 h for RTX(red) vs. 70% after 24 h for RTX(wt)). (99m)Tc(CO)(3)-RTX(red) was used without purification for in vitro and in vivo studies whereas (188)Re(CO)(3)-RTX(red) was purified to eliminate free (188)Re-precursor. Both radioimmunoconjugates were stable in human plasma for 24 h at 37 °C. In contrast, displacement experiments with excess cysteine/histidine showed significant transchelation in the case of (99m)Tc(CO)(3)-RTX(red) but not with pre-purified (188)Re(CO)(3)-RTX(red). Both conjugates revealed high binding affinity to the CD20 antigen (K(d) = 5-6 nM). Tumor uptake of (188)Re(CO)(3)-RTX(red) was 2.5 %ID/g and 0.8 %ID/g for (99m)Tc(CO)(3)-RTX(red) 48 h after injection. The values for other organs and tissues were similar for both compounds, for example the tumor-to-blood and tumor-to-liver ratios were 0.4 and 0.3 for (99m)Tc(CO)(3)-RTX(red) and for (188)Re(CO)(3)-RTX(red) 0.5 and 0.5 (24 h pi).Rituximab could be directly and stably labeled with the matched pair (99m)Tc/(188)Re using the IsoLink technology under retention of the biological activity. Labeling kinetics and yields need further improvement for potential routine application in radioimmunodiagnosis and therapy." @default.
• W2124673635 created "2016-06-24" @default.
• W2124673635 creator A5013420708 @default.
• W2124673635 creator A5041743198 @default.
• W2124673635 creator A5049116117 @default.
• W2124673635 creator A5049998908 @default.
• W2124673635 creator A5056614563 @default.
• W2124673635 creator A5064964627 @default.
• W2124673635 creator A5065629726 @default.
• W2124673635 creator A5081227680 @default.
• W2124673635 date "2011-01-01" @default.
• W2124673635 modified "2023-10-06" @default.
• W2124673635 title "Radiolabeling of rituximab with 188Re and 99mTc using the tricarbonyl technology" @default.
• W2124673635 cites W159968576 @default.
• W2124673635 cites W1605490057 @default.
• W2124673635 cites W1964599102 @default.
• W2124673635 cites W1972931253 @default.
• W2124673635 cites W1976815698 @default.
• W2124673635 cites W1983046149 @default.
• W2124673635 cites W1985200042 @default.
• W2124673635 cites W1989270330 @default.
• W2124673635 cites W1989655975 @default.
• W2124673635 cites W1991130269 @default.
• W2124673635 cites W1991255002 @default.
• W2124673635 cites W1993575340 @default.
• W2124673635 cites W2022503045 @default.
• W2124673635 cites W2039928024 @default.
• W2124673635 cites W2044410500 @default.
• W2124673635 cites W2051500196 @default.
• W2124673635 cites W2052275340 @default.
• W2124673635 cites W2058426435 @default.
• W2124673635 cites W206701898 @default.
• W2124673635 cites W2069207490 @default.
• W2124673635 cites W2082292083 @default.
• W2124673635 cites W2084687819 @default.
• W2124673635 cites W2094240872 @default.
• W2124673635 cites W2102369350 @default.
• W2124673635 cites W2106186085 @default.
• W2124673635 cites W2121521155 @default.
• W2124673635 cites W2122125156 @default.
• W2124673635 cites W2129640523 @default.
• W2124673635 cites W2130662409 @default.
• W2124673635 cites W2327135475 @default.
• W2124673635 cites W2023243630 @default.
• W2124673635 doi "https://doi.org/10.1016/j.nucmedbio.2010.05.010" @default.
• W2124673635 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21220126" @default.
• W2124673635 hasPublicationYear "2011" @default.
• W2124673635 type Work @default.
• W2124673635 sameAs 2124673635 @default.
• W2124673635 citedByCount "24" @default.
• W2124673635 countsByYear W21246736352012 @default.
• W2124673635 countsByYear W21246736352014 @default.
• W2124673635 countsByYear W21246736352015 @default.
• W2124673635 countsByYear W21246736352016 @default.
• W2124673635 countsByYear W21246736352017 @default.
• W2124673635 countsByYear W21246736352021 @default.
• W2124673635 countsByYear W21246736352022 @default.
• W2124673635 crossrefType "journal-article" @default.
• W2124673635 hasAuthorship W2124673635A5013420708 @default.
• W2124673635 hasAuthorship W2124673635A5041743198 @default.
• W2124673635 hasAuthorship W2124673635A5049116117 @default.
• W2124673635 hasAuthorship W2124673635A5049998908 @default.
• W2124673635 hasAuthorship W2124673635A5056614563 @default.
• W2124673635 hasAuthorship W2124673635A5064964627 @default.
• W2124673635 hasAuthorship W2124673635A5065629726 @default.
• W2124673635 hasAuthorship W2124673635A5081227680 @default.
• W2124673635 hasConcept C121332964 @default.
• W2124673635 hasConcept C148898269 @default.
• W2124673635 hasConcept C150903083 @default.
• W2124673635 hasConcept C153911025 @default.
• W2124673635 hasConcept C159654299 @default.
• W2124673635 hasConcept C16232356 @default.
• W2124673635 hasConcept C18031839 @default.
• W2124673635 hasConcept C185592680 @default.
• W2124673635 hasConcept C202751555 @default.
• W2124673635 hasConcept C203014093 @default.
• W2124673635 hasConcept C207001950 @default.
• W2124673635 hasConcept C2776146153 @default.
• W2124673635 hasConcept C2777807558 @default.
• W2124673635 hasConcept C2779338263 @default.
• W2124673635 hasConcept C2780653079 @default.
• W2124673635 hasConcept C502942594 @default.
• W2124673635 hasConcept C542903549 @default.
• W2124673635 hasConcept C55493867 @default.
• W2124673635 hasConcept C62520636 @default.
• W2124673635 hasConcept C71924100 @default.
• W2124673635 hasConcept C86803240 @default.
• W2124673635 hasConceptScore W2124673635C121332964 @default.
• W2124673635 hasConceptScore W2124673635C148898269 @default.
• W2124673635 hasConceptScore W2124673635C150903083 @default.
• W2124673635 hasConceptScore W2124673635C153911025 @default.
• W2124673635 hasConceptScore W2124673635C159654299 @default.
• W2124673635 hasConceptScore W2124673635C16232356 @default.
• W2124673635 hasConceptScore W2124673635C18031839 @default.
• W2124673635 hasConceptScore W2124673635C185592680 @default.
• W2124673635 hasConceptScore W2124673635C202751555 @default.
• W2124673635 hasConceptScore W2124673635C203014093 @default.
• W2124673635 hasConceptScore W2124673635C207001950 @default.

• next